Detection of circulating tumor cells in different stages of prostate cancer

Prognostic Role and HER2 Expression of Circulating Tumor Cells in Peripheral Blood of Patients Prior to Radical Cystectomy: A Prospective Study

(2012) Michael Rink et al.   EUROPEAN UROLOGY

Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance

(2011) Yun-Fan Sun et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Detection of circulating tumour cells in peripheral blood of patients with advanced non-metastatic bladder cancer

(2010) Michael Rink et al.   BJU INTERNATIONAL

Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer

(2009) S. J. Cohen et al.   ANNALS OF ONCOLOGY

Circulating Tumor Cells in Patients with Castration-Resistant Prostate Cancer Baseline Values and Correlation with Prognostic Factors

(2009) O. B. Goodman et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Prognostic Significance of Circulating Tumor Cells in Patients With Hormone Refractory Prostate Cancer

(2009) Takatsugu Okegawa et al.   JOURNAL OF UROLOGY

Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data

(2009) Howard I Scher et al.   LANCET ONCOLOGY

Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience

(2008) D. Olmos et al.   ANNALS OF ONCOLOGY

Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer

(2008) J. S. de Bono et al.   CLINICAL CANCER RESEARCH

Circulating Tumor Cells in Peripheral Blood Samples From Patients With Increased Serum Prostate Specific Antigen: Initial Results in Early Prostate Cancer

(2008) John W. Davis et al.   JOURNAL OF UROLOGY